SDMHF (Sartorius Stedim Biotech) Margin of Safety % (DCF FCF Based): -25.82% (As of Jun. 24, 2026)


SDMHF Sartorius Stedim Biotech SA SDMHF
80 GF Score
Price $190.88
GF Value $239.66
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sartorius Stedim Biotech Margin of Safety % (DCF FCF Based)?

Sartorius Stedim Biotech SDMHF +2.46% 80 Margin of Safety % (DCF FCF Based) is -25.82% as of Jun. 24, 2026. GuruFocus rates SDMHF with a GF Score™ of 80/100 and a GF Value™ of $239.66 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-24), Sartorius Stedim Biotech's Predictability Rank is 1.5-Stars. Sartorius Stedim Biotech's intrinsic value calculated from the Discounted FCF model is $51.09 and current share price is $190.88. Consequently,

Sartorius Stedim Biotech's Margin of Safety % (DCF FCF Based) using Discounted FCF model is -25.82%.

SDMHF vs ISRG, BDX, MDLN: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sartorius Stedim Biotech Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's Margin of Safety % (DCF FCF Based) falls into.


SDMHF
80GF Score
Sartorius Stedim Biotech SA SDMHF
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sartorius Stedim Biotech Margin of Safety % (DCF FCF Based) Calculation

Sartorius Stedim Biotech's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(151.71-190.88)/151.71
=-25.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

What does a Margin of Safety % (DCF FCF Based) of -25.82% mean?
Sartorius Stedim Biotech (SDMHF) has a Margin of Safety % (DCF FCF Based) of -25.82% as of Jun. 24, 2026. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on Sartorius Stedim Biotech.
Is Sartorius Stedim Biotech's Margin of Safety % (DCF FCF Based) too high?
Sartorius Stedim Biotech's current Margin of Safety % (DCF FCF Based) is -25.82%. Overall, Sartorius Stedim Biotech has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sartorius Stedim Biotech's Margin of Safety % (DCF FCF Based) compare to ISRG and BDX?
Sartorius Stedim Biotech's Margin of Safety % (DCF FCF Based) of -25.82% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF FCF Based) for a Medical Devices & Instruments company?
A good Margin of Safety % (DCF FCF Based) depends on the Medical Devices & Instruments industry context. However, Margin of Safety % (DCF FCF Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF FCF Based) mean?
A high Margin of Safety % (DCF FCF Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on Sartorius Stedim Biotech. Sartorius Stedim Biotech's current Margin of Safety % (DCF FCF Based) is -25.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius Stedim Biotech stock overvalued right now?
Based on GuruFocus' analysis, Sartorius Stedim Biotech (SDMHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $239.66, compared to a current price of $190.88 — trading 20.4% below its estimated fair value. The current Margin of Safety % (DCF FCF Based) is -25.82%. Sartorius Stedim Biotech's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF FCF Based) calculated?
Margin of Safety % (DCF FCF Based) is calculated from a company's financial statements. For Sartorius Stedim Biotech (SDMHF), the current Margin of Safety % (DCF FCF Based) is -25.82% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sartorius Stedim Biotech (SDMHF) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius Stedim Biotech stock appears to be undervalued. The current stock price of $190.88 is trading 20.4% below its estimated GF Value™ of $239.66. GuruFocus considers Sartorius Stedim Biotech to be Modestly Undervalued.

Key valuation signals for SDMHF:

  • Margin of Safety % (DCF FCF Based): -25.82%
  • GF Value™: $239.66 vs. price of $190.88 (20.4% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the SDMHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sartorius Stedim Biotech Business Description

Address Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
80GF Score

Get the complete analysis for SDMHF

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$190.88
Price
$239.66
GF Value